KMKatarina Michalcova

Katarina Michalcova

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Katarina Michalcova has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Adriana Kolesarova

    AgroBioTech Research Centre, Slovak University of Agriculture in Nitra, Tr. A. Hlinku 2, 949 76 Nitra, Slovakia

    2 shared publications
  • Marek Halenar

    Faculty of Biotechnology and Food Sciences , Slovak University of Agriculture in Nitra , Nitra , Slovak Republic

    2 shared publications
  • Shubhadeep Roychoudhury

    Department of Life Science and Bioinformatics Assam University Silchar India

    2 shared publications
  • Bibiana Klinerova

    A Department of Animal Physiology, Faculty of Biotechnology and Food Sciences , Slovak University of Agriculture in Nitra , Nitra , Slovak Republic

    1 shared publication
  • Branislav Gálik

    Institute of Nutrition and Genomics, Faculty of Agrobiology and Food Resources, Slovak University of Agriculture in Nitra, Tr. A. Hlinku 2, 949 76 Nitra, Slovakia

    1 shared publication
  • Dagmara Packova

    A Department of Animal Physiology, Faculty of Biotechnology and Food Sciences , Slovak University of Agriculture in Nitra , Nitra , Slovak Republic

    1 shared publication

Latest Publications

  • In vitro response of human ovarian cancer cells to dietary bioflavonoid isoquercitrin

    by Katarina Michalcova, Shubhadeep Roychoudhury, Marek Halenar, Eva Tvrda, Eva Kovacikova, Jaromir Vasicek, Peter Chrenek, Simona Baldovska, Luboslav Sanislo, Vladimir Kren, et al.

    Isoquercitrin is a dietary bioflavonoid used as a food supplement. We studied the mechanism underlying its effect in human ovarian cancer cells using OVCAR-3 cell line. Viability, survival, apoptosis, release of human transforming growth factor-β1 (TGF-β1) and TGF-β1 receptor, and intracellular reactive oxygen species (ROS) generation by OVCAR-3 cells were examined after isoquercitrin treatment at concentrations 5, 10, 25, 50, and 100 μg mL−1. AlamarBlue assay revealed that isoquercitrin did not cause any significant change (P > 0.05) in cell viability as compared to control. Apoptotic assay using flow cytometry did not find any significant change (P > 0.05) in the proportion of live, dead and apoptotic cells as compared to control. ELISA also showed that the release of human TGF-β1 and TGF-β1 receptor were not significantly (P > 0.05) affected by isoquercitrin as compared to control. Chemiluminescence assay demonstrated that lower concentrations (5, 10, and 25 μg mL−1) were able to exhibit beneficial effects by inhibiting the generation of intracellular ROS. In contrast, elevated concentrations of 50 and 100 μg mL−1 led to oxidative stress (P < 0.05). We concluded that the beneficial effect of isoquercitrin on ovarian cancer cells may be mediated by an antioxidative pathway that involves inhibition of intracellular ROS generation, thereby limiting oxidative stress.


  • Dietary bioflavonoid quercetin modulates porcine ovarian granulosa cell functions in vitro

    by Adriana Kolesarova, Shubhadeep Roychoudhury, Bibiana Klinerova, Dagmara Packova, Katarina Michalcova, Marek Halenar, Jana Kopcekova, Erika Mnahoncakova, Branislav Galik

    Quercetin is a dietary bioflavonoid used widely as a food supplement and is generally recognized as safe. The aim of this in vitro study was to examine the steroid hormone (progesterone and 17- β estradiol) release, proliferation (PCNA and cyclin B1) and apoptosis (caspase 3 and p53) of porcine ovarian granulosa cells after the addition of quercetin at concentrations 0.01, 0.1, 1, 10 and 100 μmol L−1. Progesterone release was stimulated at the concentration 10 μmol L−1. Quercetin neither had any impact on 17-β estradiol secretion nor on the presence of PCNA. However, a significant enhancement of the occurrence of cyclin B1 was noted except for the lowest concentration 0.01 μmol L−1. Quercetin did not have any influence on the number of granulosa cells containing caspase 3, but at the concentration 10 μmol L−1 it inhibited p53 occurrence. Results confirm the safety of quercetin in porcine ovarian granulosa cell model and further suggest its possible concentration-dependent influence on ovarian functions through pathway that may involve progesterone, cyclin B1 and p53.